Global Biopharmaceutical Manufacturing Market Price Trends, Size, Share and Forecast 2017-2022
To know more about market, click here: http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market The global biopharmaceutical manufacturing industry has witnessed a balanced growth over the past several years, owing to the increasing popularity of biopharmaceuticals along with capacity expansions, advancements in technology and the emerging trend of outsourcing activities. Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: http://www.imarcgroup.com Follow us on twitter: @imarcglobal
To know more about market, click here: http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market
The global biopharmaceutical manufacturing industry has witnessed a balanced growth over the past several years, owing to the increasing popularity of biopharmaceuticals along with capacity expansions, advancements in technology and the emerging trend of outsourcing activities.
Contact Us
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Biopharmaceutical</strong> <strong>Manufacturing</strong> <strong>Market</strong><br />
Report <strong>2017</strong>-2021<br />
Copyright © IMARC. All Rights Reserved
About IMARC Group<br />
Report Description<br />
IMARC is a leading advisor on management strategy <strong>and</strong> market research worldwide. We partner with<br />
clients in all sectors <strong>and</strong> regions to identify their highest-value opportunities, address their most<br />
critical challenges, <strong>and</strong> transform their businesses.<br />
IMARC’s information products include major market, scientific, economic <strong>and</strong> technological<br />
developments for business leaders in pharmaceutical, industrial, <strong>and</strong> high technology organizations.<br />
<strong>Market</strong> forecasts <strong>and</strong> industry analysis for biotechnology, advanced materials, pharmaceuticals, food<br />
<strong>and</strong> beverage, travel <strong>and</strong> tourism, nanotechnology <strong>and</strong> novel processing methods are at the top of the<br />
copay’s expertise.<br />
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies <strong>and</strong><br />
markets with close cooperation at all levels of the client organization. This ensures that our clients<br />
achieve unmatchable competitive advantage, build more proficient organizations, <strong>and</strong> secure lasting<br />
results.
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
<strong>Global</strong> <strong>Biopharmaceutical</strong> <strong>Manufacturing</strong> <strong>Market</strong>: Technological Advancements <strong>and</strong><br />
Rise in Outsourcing Activities Stimulating Growth<br />
The global biopharmaceutical manufacturing industry has witnessed a balanced growth over the<br />
past several years, owing to the increasing popularity of biopharmaceuticals along with capacity<br />
expansions, advancements in technology <strong>and</strong> the emerging trend of outsourcing activities.<br />
The latest report by IMARC Group titled, <strong>Global</strong> <strong>Biopharmaceutical</strong> <strong>Manufacturing</strong> <strong>Market</strong><br />
Report <strong>2017</strong>-2021, finds that the global biopharmaceutical manufacturing capacity has grown at a<br />
CAGR of more than 4% during 2009-2016, reaching a volume of around 4.5 Million Litres in 2016.<br />
<strong>Biopharmaceutical</strong>s currently represent the fastest growing segment in the global pharmaceuticals<br />
market on account of their various health benefits. The high returns associated with their<br />
production has also prompted a number of companies to develop <strong>and</strong> manufacture<br />
biopharmaceutical drugs. Moreover, the emergence of biosimilars coupled with capacity<br />
expansions are further expected to bolster the market growth. According to the report, the global<br />
biopharmaceutical manufacturing market is projected to reach a volume of 6.6 Million Litres by<br />
2021.<br />
Highlights of the <strong>Global</strong> <strong>Biopharmaceutical</strong> <strong>Manufacturing</strong> <strong>Market</strong>:
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
• Continuous improvements in technology <strong>and</strong> growth in outsourcing activities remain the major<br />
drivers.<br />
• Mammalian cell culture represents the largest category, accounting for the majority of<br />
production volume.<br />
• North America dominates the market, accounting for nearly half of the market share.<br />
One of the major trends in the market is the continuous improvement in technology aimed at<br />
increasing productivity. Manufacturers are focusing on processes such as continuous bioprocessing<br />
<strong>and</strong> the use of single-use or disposable devices so as to increase the yield. Moreover, owing to the<br />
significant cost savings <strong>and</strong> effectiveness as well as innovation <strong>and</strong> specific capabilities offered by<br />
the contract manufacturers, a number of companies are outsourcing various production activities<br />
to them. The contract manufacturers carry out activities ranging from the analytical testing of<br />
bioassays to testing the cell line stability <strong>and</strong> product characterisation. A large number of contract<br />
manufacturers are based in emerging regions such China <strong>and</strong> India which are progressively<br />
becoming a major destination for outsourcing.<br />
On the basis of the cell culture, the market has been divided into mammalian <strong>and</strong> microbial cell<br />
cultures. Mammalian cell culture currently represents the largest category, accounting for the<br />
majority of the production volume. This can be attributed to the large number of drugs which are<br />
Read full report @ http://www.imarcgroup.com/global-biopharmaceutical-manufacturingmarket
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
made using mammalian cell cultivation. On the basis of class, the market has been segmented into<br />
recombinant proteins, monoclonal antibodies, interferons, erythropoietin, granulocyte colonystimulating<br />
factor (G-CSF), recombinant human insulin, vaccines <strong>and</strong> human growth hormones<br />
(HGH). On the basis of region, North America currently represents the largest market, accounting<br />
for nearly half of the total market share. Some of the key players operating in the market include<br />
Biogen Idec, Roche, Eli Lilly, Amgen, Merck & Co., Novo Nordisk, Pfizer, AbbVie, Sanofi S.A <strong>and</strong><br />
Johnson & Johnson.<br />
The report by IMARC Group has examined the global biopharmaceutical manufacturing market<br />
on the basis of:<br />
Cell Culture:<br />
• Mammalian Cell Culture<br />
• Microbial Cell Culture<br />
Class:<br />
• Monoclonal Antibodies<br />
• Recombinant Proteins<br />
• Interferon<br />
• Granulocyte Colony-Stimulating Factor (G-CSF)<br />
• Erythropoietin
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
• Recombinant Human Insulin<br />
• Vaccines<br />
• Human Growth Hormones<br />
Region:<br />
• North America<br />
• Europe<br />
• Asia<br />
Major Manufacturers:<br />
• Roche<br />
• Amgen<br />
• Novo Nordisk<br />
• AbbVie<br />
• Sanofi SA<br />
• Johnson & Johnson<br />
• Pfizer<br />
• Merck & Co.<br />
• Ely Lilly<br />
• Biogen Idec
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
Request Sample of the Report:<br />
http://www.imarcgroup.com/request?type=report&id=724&flag=B<br />
Browse Related Reports:<br />
US Generic Injectables <strong>Market</strong> @ http://www.imarcgroup.com/us-generic-injectables-market<br />
<strong>Global</strong> Anti-Aging <strong>Market</strong> @ http://www.imarcgroup.com/anti-aging-market
Report Description <strong>and</strong> Highlights<br />
Report Description<br />
© <strong>2017</strong> IMARC All Rights Reserved<br />
This Publication <strong>and</strong> all it’s contents unless otherwise mentioned are copyrighted in the name of<br />
International <strong>Market</strong> Analysis Research <strong>and</strong> Consulting (IMARC). No part of this publication may be<br />
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be<br />
used in any form or by <strong>and</strong> means graphic electronic or mechanical, including photocopying, recording,<br />
taping or by information storage or retrieval, or by any other form, without the express consent of<br />
International <strong>Market</strong> Analysis Research <strong>and</strong> Consulting (IMARC).<br />
Disclaimer: All contents <strong>and</strong> data of this publication, including forecasts, data analysis <strong>and</strong> opinion have been<br />
based on information <strong>and</strong> sources believed to be accurate <strong>and</strong> reliable at the time of publishing.<br />
International <strong>Market</strong> Analysis Research <strong>and</strong> Consulting makes no representation of warranty of any kind as to<br />
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any<br />
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.<br />
IMARC, IMARC Group <strong>and</strong> <strong>Global</strong> Therapy Insight Series are registered trademarks of International <strong>Market</strong><br />
Analysis Research <strong>and</strong> Consulting. All other trademarks used in this publication are registered trademarks of<br />
their respective companies.
Contact Us<br />
FOR MORE DETAILS<br />
Visit us at :<br />
http://www.imarcgroup.com<br />
Stay With Us:<br />
TELEPHONE: +1-631-791-1145<br />
E-MAIL: sales@imarcgroup.com
Change language